Metformin

ALPHARETTA, Ga., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Heald, the human-led, tech-enabled platform redefining Diabetes care, proudly announces that Dr. Sunita Mishra, former Chief Medical Officer of Amazon Health services and CMO for Amazon Care, has joined as an Advisory Board Member. In this role, Dr. Mishra will advise on Heald’s expansion into the employer, provider, and health system markets, bringing her deep expertise in scaling hybrid care models that connect digital technology with real human care. Dr. Mishra brings over two decades of experience at the intersection of clinical practice, consumer innovation, and large-scale healthcare delivery. At Amazon Care, she was instrumental in building and scaling the company’s hybrid primary care model for employers, integrating virtual and in-person care to improve access, convenience, and measurable outcomes. At Amazon Health Services, she focused on using artificial intelligence (AI) and cloud technologies to make healthcare more predictive, personalized, and efficient, a vision that aligns closely with Heald’s mission of data-driven, human-led care. Before that, she served as Chief Executive of Express Care and Vice President of Consumer Innovation at Providence Health & Services, where she led initiatives to make care more patient-centered and digitally accessible. The appointment follows Heald’s growing success on the direct-to-consumer front, where participants have achieved an average 15 lbs weight reduction and a 3% decrease in A1C. Nearly 98% of users have reduced medication usage, with many reducing or fully discontinuing Insulin, Metformin, and GLP-1 drugs. Building on these outcomes, interest from employers, provider organizations, and health systems has grown sharply as they seek scalable solutions that can sustainably lower chronic disease costs and improve overall employee health. As employers and provider groups increasingly turn to Heald for sustainable Diabetes reversal solutions, the company is expanding its reach through an outcomes-based pricing model, an evolution of its Money-Back Guarantee that aligns cost directly with verified health improvements. The model ensures organizations pay only for meaningful outcomes while showcasing Heald’s belief that accountability and value-based care must go hand in hand. This approach builds on the same principles Dr. Mishra helped advance at Amazon Care, where employer-focused hybrid models were designed around accessibility and measurable results. “We’ve proven that reversing Diabetes is possible when you connect real-time metabolic data with personalized expert guidance,” said Sandeep Misra, Co-Founder and Chief Growth Officer at Heald. “Employers and provider networks are realizing this approach can fundamentally change how chronic disease is managed by addressing root causes instead of symptoms. Dr. Mishra built one of the most influential employer-focused care models in the country, and her experience will be instrumental as we extend Heald’s impact across those segments.” Meeting a Growing National Need More than 38 million Americans (14.7% of all U.S. adults) live with Diabetes, and nearly 100 million adults have prediabetes, most without knowing it, according to the CDC. The condition drives over $400 billion in annual healthcare costs, much of which stems from medication dependence, preventable complications, and lost productivity. Employers alone face a projected $90 billion annual burden from Diabetes-related absenteeism and GLP-1 drug spend approaching $12,000 per member per year. Provider organizations are also struggling to balance chronic care demand with staffing and reimbursement pressures. Heald’s approach directly addresses these challenges by connecting continuous glucose monitoring (CGM), smart devices, and wearable data with a dedicated clinical team that includes physicians, nutritionists, fitness coaches, and behavioral experts. This integrated, human-led model bridges the gap between digital convenience and clinical trust, empowering participants to make sustainable changes that improve outcomes and reduce costs for organizations. “Technology alone doesn’t solve healthcare, it’s how we use it to empower people that matters,” said Dr. Sunita Mishra. “What Heald has built is special: a model where human care and digital intelligence work hand-in-hand to drive real, sustainable change. I’m excited to help bring that impact to employers and provider groups ready to make metabolic health a strategic priority.” About Heald Heald is a human-led, tech-enabled health platform that helps people reverse Type 2 Diabetes by addressing the root causes of disease- nutrition, movement, sleep, and stress. Heald connects individuals with smart devices and a multidisciplinary clinical team to provide real-time insights, personalized coaching, and sustainable health transformation. Learn more about Heald’s approach and Money-Back Guarantee at www.iheald.com. Media Contact:Govind KumarPress and Media Relations, Healdgovind@iheald.com www.iheald.com

Innovative telehealth startup introduces inhalable ED and migraine relief plus a gut-friendly metformin gummy for blood sugar and longevity SAN DIEGO, Oct. 27, 2025 /PRNewswire/ -- ForHumanity Health Inc. today announced its public launch, introducing the only doctor-prescribed erectile dysfunction (ED) treatment powered by breath — VigorAir™, a dry-powder inhaler formulation of sildenafil (the active ingredient in Viagra®) delivered via a breath-activated inhaler and designed to reach the bloodstream through the lungs—without relying on digestion. ForHumanity's proprietary technology transforms raw materials into precision-engineered therapeutic products. Unlike traditional pills that can take an hour or more to act, and often cause stomach upset, ForHumanity's micro-encapsulation technology enables nominal doses designed for rapid uptake that are more gut-friendly since they don't rely on digestion. The result: a smarter, more human way to manage health. The company is also unveiling MetaChew™, a gut-friendly metformin gummy designed to improve adherence by reducing GI side effects, and ZapMigraine™, an inhalable dry-powder inhalation treatment for rapid migraine relief. A $100 BILLION CHALLENGE For decades, patients have been stuck with prescribed high-dose oral medications that can stress the gut, delay relief, and cause unnecessary side effects. That's a broken model for: 30M men with erectile dysfunction — 34% abandon pills due to slow onset and side effects (National Institutes of Health). 96M Americans with prediabetes — plus millions using metformin for longevity. GI side effects are common, affecting up to 25% of patients, and about 5% discontinue therapy entirely due to intolerance (Centers for Disease Control and Prevention). 39M migraine sufferers — 95% cite unmet needs for faster, more reliable relief (American Migraine Foundation). THE APPROACH: NOVEL DELIVERY SYSTEMS ForHumanity's launch sequence flips this paradigm with first-in-class delivery systems: VigorAir™ (Debut Offering): An inhalable alternative to traditional ED medication, and the same active ingredient in Viagra®, backed by decades of clinical efficacy. A discreet, propellant-free inhaler designed to deliver results directly into the bloodstream via the lungs without relying on digestion, restoring intimacy without the wait. MetaChew™ (Fall/Winter 2025): Among the first U.S. doctor-prescribed metformin gummy options, featuring ForHumanity's pioneering microencapsulation coating, designed to bypass the stomach and reduce GI side effects. Metformin is not only the second most prescribed drug in the U.S.; it is also increasingly used off-label for longevity, weight management and metabolic optimization. ZapMigraine™ (Fall/Winter 2025): Among the first doctor-prescribed, dry-powder inhaled migraine options in the U.S, designed for rapid pulmonary uptake through the lungs that does not rely on digestion. "This is the future of medicine —more convenient routes and right‑sized nominal doses where appropriate, delivered in ways that fit patients' lives," added Dr. Eva Selhub, Chief of Medical Affairs. "I'm thrilled to be part of the team that is creating new delivery methods so patients are more resilient and in tune with their health." A TRUE PLATFORM FOR THE FUTURE OF HEALTH AND WELLBEING ForHumanity is building a precision health platform. Every therapy will be paired with premium organic supplements and physician-prescribed peptides to create integrated health "stacks" that treat acute symptoms while supporting long-term resilience. "Patients are tired of waiting an hour for a pill to kick in or dealing with side effects they don't need," said James Messer, CEO and Co-Founder. "With ForHumanity, you can take control of your health on your terms, when timing matters. Our technology isn't just about making medication easier to take. It's about unlocking a new layer of control over how our bodies perform and heal, and making biohacking more accessible to as many people as possible." ForHumanity is built with trust and privacy at its core: the process is fully HIPAA-compliant, ensuring that all patient data is safeguarded to the highest medical privacy standards. ForHumanity also works with Freshpaint to carefully manage tracking and analytics, ensuring that no sensitive or personally identifiable health data is ever sent to third parties. ACCESS MADE SIMPLE Patients start with a quick online health profile and consult with a licensed healthcare provider on their telehealth site at forhumanity.co. If treatment is right for them and prescribed, memberships are designed to fit your lifestyle—whether you need occasional support or ongoing, everyday care—with continuous access to licensed healthcare providers to keep you on track. Memberships for VigorAir™ start at $10.99 per dose, while MetaChew™ and ZapMigraine™ plan options will be available later this year. All ForHumanity products are shipped in discreet packaging with free two-day delivery in the U.S. WHAT'S NEXT As people continue to focus on the best ways to manage their own wellbeing and the benefits of biohacking, ForHumanity will be there as a trusted partner and resource across their healthcare journey and lifestyle transformation. ForHumanity's roadmap extends beyond ED, metabolic health, and migraine relief, and future launches will continue to offer products that optimize people's health and wellbeing journeys — all delivered through innovative inhalers, gut-friendly formulations, and premium supplements paired with physician-prescribed peptides. For more information, visit forhumanity.co. About ForHumanity: Launched in 2025, ForHumanity Health Inc. is a telehealth company focused on building a future where healthcare feels human again. Our mission is simple: to deliver holistic, high-impact care by integrating personalized medicine, nutraceuticals, and community-based support. We're redefining how medicine works—at the molecular level. Through cutting-edge, patented micro-encapsulation technology, we deliver precision therapies exactly where they're needed—fast, efficient, and reliable. SOURCE ForHumanity WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED